AHSG and obesity disorder: Elevated fetuin-A levels have been associated with the development of a variety of liver-related metabolic issues, including IR, adipocyte inflammation, hepatocyte fibrosis, dyslipidemia, progressive macrophage infiltration, and increased toll-like receptor-4 (TLR4) expression resulting in obesity [18].